• Parkinson’s Research

  Aptinyx Prepares to Launch Phase 2 Trial of NYX-458 in PD Patients

  Posted by Community Member on May 27, 2019 at 12:33 pm

  Click here to read about Aptinyx’s plans to launch a Phase 2 trial of its investigational NYX-458 small molecule compound in people with Parkinson’s disease.

  What do you think about this news?

  replied 1 Member · 0 Replies
• 0 Replies

Log In to Reply